APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

ICAD (Intracranial Atherosclerotic Disease) Pathology

Intracranial atherosclerotic disease is the progressive narrowing of the cerebral arteries within the skull (intracranial). The arteries that supply oxygen-enriched blood to the brain are the carotid arteries and the vertebral arteries. The circle of Willis is the area at the base of the brain that joins these arteries. Stenosis (narrowing) of the artery walls in intracranial atherosclerotic disease (ICAD) develops similarly to atherosclerosis of the heart: from the buildup of plaque, also known as an atherosclerotic lesion. The product in this report is Stent and PTA balloon for Treatment of ICAD.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Intracranial atherosclerotic disease is the progressive narrowing of the cerebral arteries within the skull (intracranial). The arteries that supply oxygen-enriched blood to the brain are the carotid arteries and the vertebral arteries. The circle of Willis is the area at the base of the brain that joins these arteries. Stenosis (narrowing) of the artery walls in intracranial atherosclerotic disease (ICAD) develops similarly to atherosclerosis of the heart: from the buildup of plaque, also known as an atherosclerotic lesion. The product in this report is Stent and PTA balloon for Treatment of ICAD.

Selected research

Industry Research

ICAD (Intracranial Atherosclerotic Disease) Pathology Industry Research Report 2026

Report ID 17389447058 January 2026118 pages

Choose your research edition.

Industry ResearchICAD (Intracranial Atherosclerotic Disease) Pathology Industry Research Report 2026118 pages · $2,950 USDIndustry Growth & TrendsGlobal ICAD (Intracranial Atherosclerotic Disease) Pathology Industry Growth and Trends Forecast to 203299 pages · $3,450 USDMarket StructureGlobal ICAD (Intracranial Atherosclerotic Disease) Pathology Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032189 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal ICAD (Intracranial Atherosclerotic Disease) Pathology Market Outlook and Growth Opportunities 2026194 pages · $4,250 USDMarket Analysis & ForecastGlobal ICAD (Intracranial Atherosclerotic Disease) Pathology Market Analysis and Forecast 2026-2032193 pages · $4,950 USD

Market perspective

Intracranial atherosclerotic disease is the progressive narrowing of the cerebral arteries within the skull (intracranial). The arteries that supply oxygen-enriched blood to the brain are the carotid arteries and the vertebral arteries. The circle of Willis is the area at the base of the brain that joins these arteries. Stenosis (narrowing) of the artery walls in intracranial atherosclerotic disease (ICAD) develops similarly to atherosclerosis of the heart: from the buildup of plaque, also known as an atherosclerotic lesion. The product in this report is Stent and PTA balloon for Treatment of ICAD.

Global ICAD (Intracranial Atherosclerotic Disease) Pathology key players include Stryker, Balt, TERUMO, MicroPort, Acandis, etc. Global top five manufacturers hold a share about 90%. Asia-Pacific is the largest market, with a share about 45%, followed by North America, with a share about 25 percent. In terms of product, Stent is the largest segment, with a share about 80%. And in terms of application, the largest application is Hospital, followed by Clinic, etc.

Report Scope

Read the full market overview

This report quantifies the global ICAD (Intracranial Atherosclerotic Disease) Pathology market in terms of revenue (US$ million) and, where applicable, sales volume (Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.

It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/Units) and concentration ratios (CR5/CR10).

The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.

Key Companies & Market Share Insights

This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.

ICAD (Intracranial Atherosclerotic Disease) Pathology Market by Company

Stryker

Balt

TERUMO

MicroPort

Acandis

ICAD (Intracranial Atherosclerotic Disease) Pathology Segment by Type

Stent

PTA Balloon

ICAD (Intracranial Atherosclerotic Disease) Pathology Segment by Application

Hospital

Clinic

Other

ICAD (Intracranial Atherosclerotic Disease) Pathology Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global ICAD (Intracranial Atherosclerotic Disease) Pathology market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of ICAD (Intracranial Atherosclerotic Disease) Pathology and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of ICAD (Intracranial Atherosclerotic Disease) Pathology.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Research objectives, research methods, data sources, data cross-validation;

Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 3: Detailed analysis of ICAD (Intracranial Atherosclerotic Disease) Pathology manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.

Chapter 5: Production/output, value of ICAD (Intracranial Atherosclerotic Disease) Pathology by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.

Chapter 6: Consumption of ICAD (Intracranial Atherosclerotic Disease) Pathology in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.

Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 11: The main points and conclusions of the report.

More report detail

Tables and figures
List of Tables Table 1. Secondary Sources Table 2. Primary Sources Table 3. Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Volume and Revenue Market Size and CAGR of Manufacturers (2021 Versus 2025) Table 6. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales (Units) of Manufacturers (2021-2026) Table 7. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Market Share by Manufacturers (2021-2026) Table 8. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue of Manufacturers (2021-2026) Table 9. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Share by Manufacturers (2021-2026) Table 10. Global Market ICAD (Intracranial Atherosclerotic Disease) Pathology Average Price (USD/Unit) of Manufacturers (2021-2026) Table 11. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Industry Ranking, 2024 VS 2025 VS 2026 Table 12. Global Manufacturers of ICAD (Intracranial Atherosclerotic Disease) Pathology, Manufacturing Sites & Headquarters Table 13. Global Manufacturers of ICAD (Intracranial Atherosclerotic Disease) Pathology, Product Type & Application Table 14. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Manufacturers Established Date Table 15. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 16. Global ICAD (Intracranial Atherosclerotic Disease) Pathology by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 17. Manufacturers Mergers & Acquisitions, Expansion Plans) Table 18. Stryker Company Information Table 19. Stryker Business Overview Table 20. Stryker ICAD (Intracranial Atherosclerotic Disease) Pathology Sales (Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 21. Stryker ICAD (Intracranial Atherosclerotic Disease) Pathology Product Portfolio Table 22. Stryker Recent Developments Table 23. Balt Company Information Table 24. Balt Business Overview Table 25. Balt ICAD (Intracranial Atherosclerotic Disease) Pathology Sales (Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 26. Balt ICAD (Intracranial Atherosclerotic Disease) Pathology Product Portfolio Table 27. Balt Recent Developments Table 28. TERUMO Company Information Table 29. TERUMO Business Overview Table 30. TERUMO ICAD (Intracranial Atherosclerotic Disease) Pathology Sales (Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 31. TERUMO ICAD (Intracranial Atherosclerotic Disease) Pathology Product Portfolio Table 32. TERUMO Recent Developments Table 33. MicroPort Company Information Table 34. MicroPort Business Overview Table 35. MicroPort ICAD (Intracranial Atherosclerotic Disease) Pathology Sales (Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 36. MicroPort ICAD (Intracranial Atherosclerotic Disease) Pathology Product Portfolio Table 37. MicroPort Recent Developments Table 38. Acandis Company Information Table 39. Acandis Business Overview Table 40. Acandis ICAD (Intracranial Atherosclerotic Disease) Pathology Sales (Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 41. Acandis ICAD (Intracranial Atherosclerotic Disease) Pathology Product Portfolio Table 42. Acandis Recent Developments Table 43. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Table 44. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Region (2021-2026) & (Units) Table 45. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Market Share by Region (2021-2026) Table 46. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Region (2027-2032) & (Units) Table 47. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Market Share by Region (2027-2032) Table 48. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue by Region (2021-2026) & (US$ Million) Table 49. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Market Share by Region (2021-2026) Table 50. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue by Region (2027-2032) & (US$ Million) Table 51. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Market Share by Region (2027-2032) Table 52. North America ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 53. North America ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Country (2021-2026) & (Units) Table 54. North America ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Country (2027-2032) & (Units) Table 55. North America ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue by Country (2021-2026) & (US$ Million) Table 56. North America ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue by Country (2027-2032) & (US$ Million) Table 57. Europe ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 58. Europe ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Country (2021-2026) & (Units) Table 59. Europe ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Country (2027-2032) & (Units) Table 60. Europe ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue by Country (2021-2026) & (US$ Million) Table 61. Europe ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue by Country (2027-2032) & (US$ Million) Table 62. Asia Pacific ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 63. Asia Pacific ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Country (2021-2026) & (Units) Table 64. Asia Pacific ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Country (2027-2032) & (Units) Table 65. Asia Pacific ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue by Country (2021-2026) & (US$ Million) Table 66. Asia Pacific ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue by Country (2027-2032) & (US$ Million) Table 67. South America ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 68. South America ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Country (2021-2026) & (Units) Table 69. South America ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Country (2027-2032) & (Units) Table 70. South America ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue by Country (2021-2026) & (US$ Million) Table 71. South America ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue by Country (2027-2032) & (US$ Million) Table 72. Middle East and Africa ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 73. Middle East and Africa ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Country (2021-2026) & (Units) Table 74. Middle East and Africa ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Country (2027-2032) & (Units) Table 75. Middle East and Africa ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue by Country (2021-2026) & (US$ Million) Table 76. Middle East and Africa ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue by Country (2027-2032) & (US$ Million) Table 77. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Type (2021-2026) & (Units) Table 78. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Type (2027-2032) & (Units) Table 79. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Market Share by Type (2021-2026) Table 80. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Market Share by Type (2027-2032) Table 81. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue by Type (2021-2026) & (US$ Million) Table 82. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue by Type (2027-2032) & (US$ Million) Table 83. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Market Share by Type (2021-2026) Table 84. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Market Share by Type (2027-2032) Table 85. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Price by Type (2021-2026) & (USD/Unit) Table 86. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Price by Type (2027-2032) & (USD/Unit) Table 87. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Application (2021-2026) & (Units) Table 88. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Application (2027-2032) & (Units) Table 89. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Market Share by Application (2021-2026) Table 90. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Market Share by Application (2027-2032) Table 91. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue by Application (2021-2026) & (US$ Million) Table 92. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue by Application (2027-2032) & (US$ Million) Table 93. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Market Share by Application (2021-2026) Table 94. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Market Share by Application (2027-2032) Table 95. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Price by Application (2021-2026) & (USD/Unit) Table 96. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Price by Application (2027-2032) & (USD/Unit) Table 97. Key Raw Materials Table 98. Raw Materials Key Suppliers Table 99. ICAD (Intracranial Atherosclerotic Disease) Pathology Distributors List Table 100. ICAD (Intracranial Atherosclerotic Disease) Pathology Customers List Table 101. ICAD (Intracranial Atherosclerotic Disease) Pathology Industry Trends Table 102. ICAD (Intracranial Atherosclerotic Disease) Pathology Industry Drivers Table 103. ICAD (Intracranial Atherosclerotic Disease) Pathology Industry Restraints Table 104. Authors List of This Report List of Figures Figure 1. Research Methodology Figure 2. Research Process Figure 3. Key Executives Interviewed Figure 4. ICAD (Intracranial Atherosclerotic Disease) Pathology Product Image Figure 5. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 6. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Market Size (2021-2032) & (US$ Million) Figure 7. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales (2021-2032) & (Units) Figure 8. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Average Price (USD/Unit) & (2021-2032) Figure 9. Stent Product Image Figure 10. PTA Balloon Product Image Figure 11. Hospital Product Image Figure 12. Clinic Product Image Figure 13. Other Product Image Figure 14. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Share by Manufacturers in 2025 Figure 15. Global Manufacturers of ICAD (Intracranial Atherosclerotic Disease) Pathology, Manufacturing Sites & Headquarters Figure 16. Global Top 5 and 10 ICAD (Intracranial Atherosclerotic Disease) Pathology Players Market Share by Revenue in 2025 Figure 17. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 18. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Figure 19. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Region in 2025 Figure 20. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue by Region in 2025 Figure 21. North America ICAD (Intracranial Atherosclerotic Disease) Pathology Market Size by Country in 2025 Figure 22. North America ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Market Share by Country (2021-2032) Figure 23. North America ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Market Share by Country (2021-2032) Figure 24. United States ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Growth Rate (2021-2032) & (US$ Million) Figure 25. Canada ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Growth Rate (2021-2032) & (US$ Million) Figure 26. Mexico ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Growth Rate (2021-2032) & (US$ Million) Figure 27. Europe ICAD (Intracranial Atherosclerotic Disease) Pathology Market Size by Country in 2025 Figure 28. Europe ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Market Share by Country (2021-2032) Figure 29. Europe ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Market Share by Country (2021-2032) Figure 30. Germany ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Growth Rate (2021-2032) & (US$ Million) Figure 31. France ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Growth Rate (2021-2032) & (US$ Million) Figure 32. U.K. ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Growth Rate (2021-2032) & (US$ Million) Figure 33. Italy ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Growth Rate (2021-2032) & (US$ Million) Figure 34. Russia ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Growth Rate (2021-2032) & (US$ Million) Figure 35. Spain ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Growth Rate (2021-2032) & (US$ Million) Figure 36. Netherlands ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Growth Rate (2021-2032) & (US$ Million) Figure 37. Switzerland ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Growth Rate (2021-2032) & (US$ Million) Figure 38. Sweden ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Growth Rate (2021-2032) & (US$ Million) Figure 39. Poland ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Growth Rate (2021-2032) & (US$ Million) Figure 40. Asia Pacific ICAD (Intracranial Atherosclerotic Disease) Pathology Market Size by Country in 2025 Figure 41. Asia Pacific ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Market Share by Country (2021-2032) Figure 42. Asia Pacific ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Market Share by Country (2021-2032) Figure 43. China ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Growth Rate (2021-2032) & (US$ Million) Figure 44. Japan ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Growth Rate (2021-2032) & (US$ Million) Figure 45. South Korea ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Growth Rate (2021-2032) & (US$ Million) Figure 46. India ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Growth Rate (2021-2032) & (US$ Million) Figure 47. Australia ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Growth Rate (2021-2032) & (US$ Million) Figure 48. Taiwan ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Growth Rate (2021-2032) & (US$ Million) Figure 49. Southeast Asia ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Growth Rate (2021-2032) & (US$ Million) Figure 50. Southeast Asia ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Growth Rate (2021-2032) & (US$ Million) Figure 51. South America ICAD (Intracranial Atherosclerotic Disease) Pathology Market Size by Country in 2025 Figure 52. South America ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Market Share by Country (2021-2032) Figure 53. South America ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Market Share by Country (2021-2032) Figure 54. Brazil ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Growth Rate (2021-2032) & (US$ Million) Figure 55. Argentina ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Growth Rate (2021-2032) & (US$ Million) Figure 56. Chile ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Growth Rate (2021-2032) & (US$ Million) Figure 57. Middle East and Africa ICAD (Intracranial Atherosclerotic Disease) Pathology Market Size by Country in 2025 Figure 58. Middle East and Africa ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Market Share by Country (2021-2032) Figure 59. Middle East and Africa ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Market Share by Country (2021-2032) Figure 60. Egypt ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Growth Rate (2021-2032) & (US$ Million) Figure 61. South Africa ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Growth Rate (2021-2032) & (US$ Million) Figure 62. Israel ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Growth Rate (2021-2032) & (US$ Million) Figure 63. Türkiye ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Growth Rate (2021-2032) & (US$ Million) Figure 64. GCC Countries ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Growth Rate (2021-2032) & (US$ Million) Figure 65. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Market Share by Type (2021-2032) Figure 66. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Market Share by Type (2021-2032) Figure 67. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Price (USD/Unit) by Type (2021-2032) Figure 68. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Market Share by Application (2021-2032) Figure 69. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Market Share by Application (2021-2032) Figure 70. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Price (USD/Unit) by Application (2021-2032) Figure 71. ICAD (Intracranial Atherosclerotic Disease) Pathology Value Chain Figure 72. ICAD (Intracranial Atherosclerotic Disease) Pathology Production Mode & Process Figure 73. Direct Comparison with Distribution Share Figure 74. Distributors Profiles Figure 75. ICAD (Intracranial Atherosclerotic Disease) Pathology Industry Opportunities and Challenges

Scope & coverage.

Types
  • Stent
  • PTA Balloon
Applications
  • Hospital
  • Clinic
  • Other
Companies covered
  • Stryker
  • Balt
  • TERUMO
  • MicroPort
  • Acandis

Inside the report.

1 Preface
  1. 1.1 Scope of Report
  2. 1.2 Reasons for Doing This Study
  3. 1.3 Research Methodology
  4. 1.4 Research Process
  5. 1.5 Data Source
  6. 1.5.1 Secondary Sources
  7. 1.5.2 Primary Sources
2 Market Overview
  1. 2.1 Product Definition
  2. 2.2 Global Market Growth Prospects
  3. 2.2.1 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Market Size (2021-2032)
  4. 2.2.2 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales (2021-2032)
  5. 2.2.3 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Market Average Price (2021-2032)
  6. 2.3 ICAD (Intracranial Atherosclerotic Disease) Pathology by Type
  7. 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
  8. 2.3.2 Stent
  9. 2.3.3 PTA Balloon
  10. 2.4 ICAD (Intracranial Atherosclerotic Disease) Pathology by Application
  11. 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
  12. 2.4.2 Hospital
  13. 2.4.3 Clinic
  14. 2.4.4 Other
3 Market Competitive Landscape by Manufacturers
  1. 3.1 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Market Competitive Situation by Manufacturers (2021 Versus 2025)
  2. 3.2 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales (Units) of Manufacturers (2021-2026)
  3. 3.3 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue of Manufacturers (2021-2026)
  4. 3.4 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Average Price by Manufacturers (2021-2026)
  5. 3.5 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Industry Ranking, 2024 VS 2025 VS 2026
  6. 3.6 Global Manufacturers of ICAD (Intracranial Atherosclerotic Disease) Pathology, Manufacturing Sites & Headquarters
  7. 3.7 Global Manufacturers of ICAD (Intracranial Atherosclerotic Disease) Pathology, Product Type & Application
  8. 3.8 Global Manufacturers of ICAD (Intracranial Atherosclerotic Disease) Pathology, Established Date
  9. 3.9 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Market CR5 and HHI
  10. 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
  1. 4.1 Stryker
  2. 4.1.1 Stryker Company Information
  3. 4.1.2 Stryker Business Overview
  4. 4.1.3 Stryker ICAD (Intracranial Atherosclerotic Disease) Pathology Sales, Revenue and Gross Margin (2021-2026)
  5. 4.1.4 Stryker ICAD (Intracranial Atherosclerotic Disease) Pathology Product Portfolio
  6. 4.1.5 Stryker Recent Developments
  7. 4.2 Balt
  8. 4.2.1 Balt Company Information
  9. 4.2.2 Balt Business Overview
  10. 4.2.3 Balt ICAD (Intracranial Atherosclerotic Disease) Pathology Sales, Revenue and Gross Margin (2021-2026)
  11. 4.2.4 Balt ICAD (Intracranial Atherosclerotic Disease) Pathology Product Portfolio
  12. 4.2.5 Balt Recent Developments
  13. 4.3 TERUMO
  14. 4.3.1 TERUMO Company Information
  15. 4.3.2 TERUMO Business Overview
  16. 4.3.3 TERUMO ICAD (Intracranial Atherosclerotic Disease) Pathology Sales, Revenue and Gross Margin (2021-2026)
  17. 4.3.4 TERUMO ICAD (Intracranial Atherosclerotic Disease) Pathology Product Portfolio
  18. 4.3.5 TERUMO Recent Developments
  19. 4.4 MicroPort
  20. 4.4.1 MicroPort Company Information
  21. 4.4.2 MicroPort Business Overview
  22. 4.4.3 MicroPort ICAD (Intracranial Atherosclerotic Disease) Pathology Sales, Revenue and Gross Margin (2021-2026)
  23. 4.4.4 MicroPort ICAD (Intracranial Atherosclerotic Disease) Pathology Product Portfolio
  24. 4.4.5 MicroPort Recent Developments
  25. 4.5 Acandis
  26. 4.5.1 Acandis Company Information
  27. 4.5.2 Acandis Business Overview
  28. 4.5.3 Acandis ICAD (Intracranial Atherosclerotic Disease) Pathology Sales, Revenue and Gross Margin (2021-2026)
  29. 4.5.4 Acandis ICAD (Intracranial Atherosclerotic Disease) Pathology Product Portfolio
  30. 4.5.5 Acandis Recent Developments
5 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Market Scenario by Region
  1. 5.1 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Market Size by Region: 2021 VS 2025 VS 2032
  2. 5.2 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Region: 2021-2032
  3. 5.2.1 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Region: 2021-2026
  4. 5.2.2 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Region: 2027-2032
  5. 5.3 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue by Region: 2021-2032
  6. 5.3.1 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue by Region: 2021-2026
  7. 5.3.2 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue by Region: 2027-2032
  8. 5.4 North America ICAD (Intracranial Atherosclerotic Disease) Pathology Market Facts & Figures by Country
  9. 5.4.1 North America ICAD (Intracranial Atherosclerotic Disease) Pathology Market Size by Country: 2021 VS 2025 VS 2032
  10. 5.4.2 North America ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Country (2021-2032)
  11. 5.4.3 North America ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue by Country (2021-2032)
  12. 5.4.4 United States
  13. 5.4.5 Canada
  14. 5.4.6 Mexico
  15. 5.5 Europe ICAD (Intracranial Atherosclerotic Disease) Pathology Market Facts & Figures by Country
  16. 5.5.1 Europe ICAD (Intracranial Atherosclerotic Disease) Pathology Market Size by Country: 2021 VS 2025 VS 2032
  17. 5.5.2 Europe ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Country (2021-2032)
  18. 5.5.3 Europe ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue by Country (2021-2032)
  19. 5.5.4 Germany
  20. 5.5.5 France
  21. 5.5.6 U.K.
  22. 5.5.7 Italy
  23. 5.5.8 Russia
  24. 5.5.9 Spain
  25. 5.5.10 Netherlands
  26. 5.5.11 Switzerland
  27. 5.5.12 Sweden
  28. 5.5.13 Poland
  29. 5.6 Asia Pacific ICAD (Intracranial Atherosclerotic Disease) Pathology Market Facts & Figures by Country
  30. 5.6.1 Asia Pacific ICAD (Intracranial Atherosclerotic Disease) Pathology Market Size by Country: 2021 VS 2025 VS 2032
  31. 5.6.2 Asia Pacific ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Country (2021-2032)
  32. 5.6.3 Asia Pacific ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue by Country (2021-2032)
  33. 5.6.4 China
  34. 5.6.5 Japan
  35. 5.6.6 South Korea
  36. 5.6.7 India
  37. 5.6.8 Australia
  38. 5.6.9 Taiwan
  39. 5.6.10 Southeast Asia
  40. 5.7 South America ICAD (Intracranial Atherosclerotic Disease) Pathology Market Facts & Figures by Country
  41. 5.7.1 South America ICAD (Intracranial Atherosclerotic Disease) Pathology Market Size by Country: 2021 VS 2025 VS 2032
  42. 5.7.2 South America ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Country (2021-2032)
  43. 5.7.3 South America ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue by Country (2021-2032)
  44. 5.7.4 Brazil
  45. 5.7.5 Argentina
  46. 5.7.6 Chile
  47. 5.8 Middle East and Africa ICAD (Intracranial Atherosclerotic Disease) Pathology Market Facts & Figures by Country
  48. 5.8.1 Middle East and Africa ICAD (Intracranial Atherosclerotic Disease) Pathology Market Size by Country: 2021 VS 2025 VS 2032
  49. 5.8.2 Middle East and Africa ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Country (2021-2032)
  50. 5.8.3 Middle East and Africa ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue by Country (2021-2032)
  51. 5.8.4 Egypt
  52. 5.8.5 South Africa
  53. 5.8.6 Israel
  54. 5.8.7 Türkiye
  55. 5.8.8 GCC Countries
6 Segment by Type
  1. 6.1 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Type (2021-2032)
  2. 6.1.1 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Type (2021-2032) & (Units)
  3. 6.1.2 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Market Share by Type (2021-2032)
  4. 6.2 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue by Type (2021-2032)
  5. 6.2.1 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Type (2021-2032) & (US$ Million)
  6. 6.2.2 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Market Share by Type (2021-2032)
  7. 6.3 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Price by Type (2021-2032)
7 Segment by Application
  1. 7.1 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Application (2021-2032)
  2. 7.1.1 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Application (2021-2032) & (Units)
  3. 7.1.2 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Market Share by Application (2021-2032)
  4. 7.2 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue by Application (2021-2032)
  5. 7.2.1 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Application (2021-2032) & (US$ Million)
  6. 7.2.2 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Market Share by Application (2021-2032)
  7. 7.3 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
  1. 8.1 ICAD (Intracranial Atherosclerotic Disease) Pathology Value Chain Analysis
  2. 8.1.1 ICAD (Intracranial Atherosclerotic Disease) Pathology Key Raw Materials
  3. 8.1.2 Raw Materials Key Suppliers
  4. 8.1.3 ICAD (Intracranial Atherosclerotic Disease) Pathology Production Mode & Process
  5. 8.2 ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Channels Analysis
  6. 8.2.1 Direct Comparison with Distribution Share
  7. 8.2.2 ICAD (Intracranial Atherosclerotic Disease) Pathology Distributors
  8. 8.2.3 ICAD (Intracranial Atherosclerotic Disease) Pathology Customers
9 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Analyzing Market Dynamics
  1. 9.1 ICAD (Intracranial Atherosclerotic Disease) Pathology Industry Trends
  2. 9.2 ICAD (Intracranial Atherosclerotic Disease) Pathology Industry Drivers
  3. 9.3 ICAD (Intracranial Atherosclerotic Disease) Pathology Industry Opportunities and Challenges
  4. 9.4 ICAD (Intracranial Atherosclerotic Disease) Pathology Industry Restraints
10 Report Conclusion
    11 Disclaimer

      GET THE RESEARCH

      Choose your license.

      Choose who needs access.
      All options are for this report and research series.

      Compare access permissions.

      Single User License
      One named user. Individual access.
      Multi User License
      Up to 5 users in the same department.
      Enterprise License
      Organization-wide access within the agreed license.

      Access applies to the purchased edition. Later editions are separate purchases.

      License options
      $2,950USD
      Buy now

      PDF by email within 3–5 working days after payment confirmation.

      Talk to an analyst
      APO Research, Inc.
      Talk to an analyst